封面
市场调查报告书
商品编码
1620672

光采术产品市场:按产品、治疗领域和最终用户 - 2025-2030 年全球预测

Photopheresis Product Market by Product (Closed System, Open System), Therapeutic Area (Autoimmune Diseases, Cutaneous T-cell Lymphoma, Graft Versus Host Diseases), End User - Global Forecast 2025-2030

出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年光采产品市值为5.1434亿美元,预计到2024年将达到5.5219亿美元,复合年增长率为7.83%,到2030年将达到8.7237亿美元。

光采术是治疗方法,主要用于治疗皮肤 T 细胞淋巴瘤、移植物抗宿主疾病和一些自体免疫疾病等疾病。这些免疫相关疾病的日益普及、医疗技术的进步以及对个人化医疗的日益重视推动了光化学疗法产品的全球市场。这种需求源于对与传统治疗方法相比副作用较少的替代疗法的需要。它们的用途很广泛,包括医院、专科诊所和门诊手术中心,可以在其中发挥治疗疾病和预防復发的作用。最终用户主要包括专门从事肿瘤学和血液学的医疗保健提供者。影响市场的主要发展因素包括患者数量的增加、医疗保健支出的增加以及对医疗基础设施快速发展的新兴市场的日益关注。将人工智慧整合到光化学疗法设备中等技术创新提供了显着的机会。然而,市场成长受到高昂的设备成本、严格的监管要求以及缺乏对治疗益处的广泛认识的限制。此外,操作和管理如此复杂的设备需要熟练的专业人员,这在欠发达地区可能是一个限制因素。这项创新研究旨在提高光化学疗法设备的功效和可负担性,并探索潜在的新临床适应症。与製药公司和学术机构的策略研究合作可以加速产品开发。此外,增加有关光化学疗法的推广和教育可以帮助占领更大的市场占有率。该市场竞争激烈,其特点是不断的技术创新,导致数位健康解决方案的整合度不断提高,从而提高治疗效果和患者的治疗效果。

主要市场统计
基准年[2023] 51434万美元
预计年份 [2024] 55219万美元
预测年份 [2030] 8.7237 亿美元
复合年增长率(%) 7.83%

市场动态:快速发展的光采产品市场的关键市场洞察

供需的动态交互作用正在改变光采产品市场。透过了解这些不断变化的市场动态,公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险,同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 自体免疫疾病和癌症疾病的盛行率上升
    • 全球医疗保健支出不断增加,人们对慢性病的认知不断增强
  • 市场限制因素
    • 光采治疗相关的高成本
  • 市场机会
    • 光化学疗法产品的技术进步
    • 光采产品製造商与医疗机构之间的合併活动
  • 市场挑战
    • 与光采术产品和治疗相关的监管和报销问题

波特的五力:驾驭光采产品市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势,解决弱点并避免潜在的挑战,从而确保更强大的市场地位。

PESTLE分析:了解光采产品市场的外部影响

外部宏观环境因素在塑造光采产品市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素,公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化,并为他们做出积极主动的决策做好准备。

市场占有率分析 了解光采产品市场的竞争状况

对光分离产品市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势,为供应商提供了製定策略决策所需的洞察力,使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵光采产品市场厂商绩效评估

FPNV定位矩阵是评估光采产品市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商,从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商,以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议,以规划光采产品市场的成功之路

光采产品市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过考虑关键资源、能力和绩效指标,公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战,利用新的商机,并取得长期成功。

本报告对市场进行了全面分析,涵盖关键重点领域:

1. 市场渗透率:详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开发:辨识新兴市场的成长机会,评估现有领域的扩张潜力,并提供未来成长的策略蓝图。

3. 市场多元化:分析近期产品发布、未开发地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报:彻底分析竞争格局,检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新:重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题,帮助相关人员做出明智的决策:

1.目前的市场规模和未来的成长预测是多少?

2. 哪些产品、区隔市场和地区提供最佳投资机会?

3.塑造市场的主要技术趋势和监管影响是什么?

4.主要厂商的市场占有率和竞争地位如何?

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么?

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 自体免疫疾病和癌症的发生率上升
      • 全球医疗保健成本不断上升,人们对慢性病的认知不断增强
    • 抑制因素
      • 光采治疗相关的高成本
    • 机会
      • 光化学疗法产品的技术进步
      • 光采产品製造商与医疗机构之间的合併活动
    • 任务
      • 与光化学疗法产品和治疗相关的监管和报销问题
  • 市场区隔分析
    • 产品:更多采用封闭式系统以提高病人安全
    • 最终用户:医院对提供综合治疗环境的光化学疗法产品的需求不断增长。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章光采产品市场:副产品

  • 封闭式系统
  • 开放系统

第七章光采术产品市场(依治疗领域)

  • 自体免疫疾病
  • 皮肤T细胞淋巴瘤
  • 移植物抗宿主疾病
  • 固态器官移植排斥反应

第八章光采产品市场:依最终用户分类

  • 门诊中心
  • 医院
  • 专科诊所

第九章 北美、南美光采产品市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太光采产品市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东、非洲光采产品市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵,2023
  • 竞争情境分析
    • 费森尤斯·卡比 (Fresenius Kabi) 为非亲分离器引入单针功能
    • 日本核准Mallinckrodt 的 CELLEX 光分离系统用于慢性 GVHD 治疗的保险报销
  • 战略分析和建议

公司名单

  • BioCardia, Inc.
  • Bristol-Myers Squibb Company
  • Fresenius SE & Co. KGaA
  • Johnson & Johnson Services, Inc.
  • Koninklijke Philips NV
  • Macopharma
  • Mallinckrodt Pharmaceuticals
  • Merck & Co., Inc.
  • Pfizer Inc.
  • PIT Medical Systems GmbH
  • Sanofi SA
  • Terumo Corporation
  • Transimmune AG
Product Code: MRR-030EE4851624

The Photopheresis Product Market was valued at USD 514.34 million in 2023, expected to reach USD 552.19 million in 2024, and is projected to grow at a CAGR of 7.83%, to USD 872.37 million by 2030.

Photopheresis, a therapeutic procedure involving the extracorporeal treatment of blood with UV light and photosensitizing agents, is primarily used to treat conditions like cutaneous T-cell lymphoma, graft versus host disease, and some autoimmune disorders. The global market for photopheresis products is driven by the increasing prevalence of these immune-related disorders, advancements in medical technologies, and a growing emphasis on personalized medicine. Its necessity stems from the need for alternative treatments that offer fewer side effects compared to conventional therapies. The applications span across hospitals, specialty clinics, and ambulatory surgical centers, where it serves as a therapeutic and sometimes preventative measure against disease relapse. End-users mainly include healthcare providers specializing in oncology and hematology. Key growth factors influencing the market include a rising patient pool, increased healthcare spending, and stronger focus on emerging markets where healthcare infrastructure is rapidly developing. Technological innovations, like the integration of AI in photopheresis machines, present notable opportunities. However, market growth is limited by the high cost of devices, stringent regulatory requirements, and a lack of widespread awareness regarding the treatment's benefits. Moreover, skilled professionals are required to operate and manage these sophisticated devices, which can be a limiting factor in underdeveloped regions. Innovative research could target improving the efficacy and affordability of photopheresis equipment and exploring potential new clinical indications. Strategic collaborations with pharmaceutical firms and academic institutions could accelerate product development. Furthermore, increasing outreach and education about photopheresis could help in capturing a larger market share. The market is highly competitive and characterized by continuous innovation, with trends pointing towards a greater integration of digital health solutions to enhance treatment efficacy and patient outcomes.

KEY MARKET STATISTICS
Base Year [2023] USD 514.34 million
Estimated Year [2024] USD 552.19 million
Forecast Year [2030] USD 872.37 million
CAGR (%) 7.83%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Photopheresis Product Market

The Photopheresis Product Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of autoimmune and cancer diseases
    • Increased global healthcare spending and growing awareness about chronic diseases
  • Market Restraints
    • High costs associated with photopheresis treatments
  • Market Opportunities
    • Technological advancements in photopheresis products
    • Amalgamation activities between photopheresis product manufacturers and healthcare institutions
  • Market Challenges
    • Regulatory and reimbursement issues associated with photopheresis products and treatments

Porter's Five Forces: A Strategic Tool for Navigating the Photopheresis Product Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Photopheresis Product Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Photopheresis Product Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Photopheresis Product Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Photopheresis Product Market

A detailed market share analysis in the Photopheresis Product Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Photopheresis Product Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Photopheresis Product Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Photopheresis Product Market

A strategic analysis of the Photopheresis Product Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Photopheresis Product Market, highlighting leading vendors and their innovative profiles. These include BioCardia, Inc., Bristol-Myers Squibb Company, Fresenius SE & Co. KGaA, Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Macopharma, Mallinckrodt Pharmaceuticals, Merck & Co., Inc., Pfizer Inc., PIT Medical Systems GmbH, Sanofi S.A., Terumo Corporation, and Transimmune AG.

Market Segmentation & Coverage

This research report categorizes the Photopheresis Product Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Closed System and Open System.
  • Based on Therapeutic Area, market is studied across Autoimmune Diseases, Cutaneous T-cell Lymphoma, Graft Versus Host Diseases, and Solid Organ Transplant Rejections.
  • Based on End User, market is studied across Ambulatory Centers, Hospitals, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of autoimmune and cancer diseases
      • 5.1.1.2. Increased global healthcare spending and growing awareness about chronic diseases
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with photopheresis treatments
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in photopheresis products
      • 5.1.3.2. Amalgamation activities between photopheresis product manufacturers and healthcare institutions
    • 5.1.4. Challenges
      • 5.1.4.1. Regulatory and reimbursement issues associated with photopheresis products and treatments
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Growing adoption of closed systems for increased patient safety
    • 5.2.2. End User: Higher need for photopheresis products in hospitals to offer a comprehensive treatment environment
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Photopheresis Product Market, by Product

  • 6.1. Introduction
  • 6.2. Closed System
  • 6.3. Open System

7. Photopheresis Product Market, by Therapeutic Area

  • 7.1. Introduction
  • 7.2. Autoimmune Diseases
  • 7.3. Cutaneous T-cell Lymphoma
  • 7.4. Graft Versus Host Diseases
  • 7.5. Solid Organ Transplant Rejections

8. Photopheresis Product Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Centers
  • 8.3. Hospitals
  • 8.4. Specialty Clinics

9. Americas Photopheresis Product Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Photopheresis Product Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Photopheresis Product Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Fresenius Kabi Introduces Single-Needle Function in Amicus Separator
    • 12.3.2. Japan Approves Reimbursement for Mallinckrodt's CELLEX Photopheresis System in Treating Chronic GVHD
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. BioCardia, Inc.
  • 2. Bristol-Myers Squibb Company
  • 3. Fresenius SE & Co. KGaA
  • 4. Johnson & Johnson Services, Inc.
  • 5. Koninklijke Philips N.V.
  • 6. Macopharma
  • 7. Mallinckrodt Pharmaceuticals
  • 8. Merck & Co., Inc.
  • 9. Pfizer Inc.
  • 10. PIT Medical Systems GmbH
  • 11. Sanofi S.A.
  • 12. Terumo Corporation
  • 13. Transimmune AG

LIST OF FIGURES

  • FIGURE 1. PHOTOPHERESIS PRODUCT MARKET RESEARCH PROCESS
  • FIGURE 2. PHOTOPHERESIS PRODUCT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS PHOTOPHERESIS PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS PHOTOPHERESIS PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES PHOTOPHERESIS PRODUCT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES PHOTOPHERESIS PRODUCT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC PHOTOPHERESIS PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC PHOTOPHERESIS PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PHOTOPHERESIS PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PHOTOPHERESIS PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. PHOTOPHERESIS PRODUCT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. PHOTOPHERESIS PRODUCT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PHOTOPHERESIS PRODUCT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PHOTOPHERESIS PRODUCT MARKET DYNAMICS
  • TABLE 7. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY CLOSED SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY OPEN SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY CUTANEOUS T-CELL LYMPHOMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY GRAFT VERSUS HOST DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY SOLID ORGAN TRANSPLANT REJECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY AMBULATORY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS PHOTOPHERESIS PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES PHOTOPHERESIS PRODUCT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC PHOTOPHERESIS PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA PHOTOPHERESIS PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. PHOTOPHERESIS PRODUCT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. PHOTOPHERESIS PRODUCT MARKET, FPNV POSITIONING MATRIX, 2023